Exchange: NASDAQ·Updated 07:34 PM EDT
FULC logo

FULC Fulcrum Therapeutics Inc

$3.82
$0.01
(0.27%)
Today
Closed $3.76
$0.06
(1.60%)
After Hours
EarningsOct 29
Mkt Cap$286.88M
Vol3.66M

About FULC

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.
48

Neutral Sentiment

How do you feel about FULC?

focafoca99
$FULC exposes a securities investigation by Kaplan Fox, urging investors to submit tips and seek compensation.

Advertisement|Remove ads.